newsfilter
← Latest News
GlobeNewswire·

Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care Conference

BOSTON, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (NASDAQ:INZY) ("Company" or "Inozyme"), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of